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Review
The U.S. Environmental Protection Agency 
(EPA) has a significant interest in develop-
ing more efficient and informative toxicity 
determination approaches in part because 
of the large number of chemicals under its 
jurisdiction. Ultimately, it would be bene- 
ficial to characterize the toxicologic profiles 
of all chemicals in use in the United States. 
However, the size of this chemical universe 
[in excess of 75,000 chemicals, which is the 
estimated number in the Toxic Substances 
Control Act (TSCA 1976) inventory (U.S. 
EPA 2004b) makes this goal too difficult 
using current approaches to toxicity charac-
terization that rely on extensive animal test-
ing, cost millions of dollars, and can take 
2–3 years per chemical. The International Life 
Sciences Institute/Health and Environmental 
Sciences Institute (ILSI/HESI) recently 
released several reports describing a more 
focused, tier-based approach for toxicity test-
ing of agricultural chemicals, which would 
ultimately lead to the use of fewer animals 
(Barton et al. 2006; Carmichael et al. 2006). 
The National Research Council (NRC) 
recently released a report titled Toxicity 
Testing in the 21st Century: A Vision and a 
Strategy that outlines a much more ambi-
tious and long-term vision for developing 
novel in vitro approaches to chemical tox-
icity charac  teri  za  tion and prediction (NRC 
2007) that would largely eliminate animal 
testing. The NRC report addresses several 
concerns about the current testing methods, 
specifically, the desire a) to reduce the num-
ber of animals used in testing, b) to reduce 
the overall cost and time required to charac-
terize each chemical, and c) to increase the 
level of mechanistic understanding of chemi-
cal toxicity. The U.S. EPA and the National 
Institutes of Health (NIH) are actively pursu-
ing approaches to implement ideas outlined 
in the NRC report (Collins et al. 2008).
Regardless of the level of quality of toxi-
cology data on environmental chemicals, 
many chemicals lack significant amounts 
of data. In the United States and Canada, 
an estimated 30,000 chemicals are in 
wide commercial use, based on U.S. EPA 
and Environment Canada data (Muir and 
Howard 2006). The European Union’s 
Registration, Evaluation, and Authorization 
of Chemicals (REACH) program has recently 
released its first set of registered substances, 
which contains > 140,000 entries (REACH 
2008). The exact number of chemicals in use 
is, in a sense, unknowable because it depends 
on where one sets the threshold of use and 
because use changes over time. The major 
point is that the number is relatively large 
and that only a relatively small subset of these 
chemicals have been sufficiently well charac-
terized for their potential to cause human or 
ecologic toxicity to support regulatory action. 
This “data gap” is well documented (Allanou 
et al. 1999; Applegate and Baer 2006; 
Birnbaum et al. 2003; Guth et al. 2005; NRC 
2007; U.S. EPA 1998).
The high cost and lengthy times associ-
ated with the use of animal testing to deter-
mine a chemical’s potential for toxicity make 
this strategy impractical for evaluating tens 
of thousands of chemicals, hence the large 
inventories of existing chemicals for which 
few or no test data are available. An alterna-
tive approach is to attempt to assess much 
larger numbers of chemicals by employing 
more efficient in vitro methods. One strategy 
applies a broad spectrum of relatively inex-
pensive and rapid high-throughput screening 
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(HTS) assays to a large set of chemicals, fol-
lowed by the use of these results to prioritize 
a much smaller subset of chemicals for more 
detailed analysis. The “prioritization score” 
for a chemical would be based on signatures, 
or patterns extracted from the HTS data, that 
are predictive of particular effects or modes 
of chemical toxicity. A comprehensive priori-
tization approach will also require the use of 
exposure and pharmacokinetic estimates, in 
addition to the intrinsic hazard information 
provided by in vitro assays. Chemicals of known   
toxicity make up the training and validation 
sets that are used to develop and validate these 
predictive signatures. HTS assays that yield 
data for the predictive signatures would then 
be run on chemicals of unknown toxicity (the 
test chemicals), and a prioritization score for 
those chemicals would be produced. The U.S. 
EPA has made a significant investment in this 
approach through the ToxCast research pro-
gram (Dix et al. 2007). ToxCast is currently 
screening hundreds, and eventually thousands, 
of environmental chemicals using hundreds of 
HTS assays with the goal to develop predictive 
toxicity signatures, and is using these signa-
tures to prioritize chemicals for further test-
ing. In this context, the term “environmental 
chemicals” refers primarily to pesticides and 
industrial chemicals that are used or produced 
in large enough quantities to pose potential for 
human or ecologic exposure [largely the high-
production-volume (HPV) and medium-pro-
duction-volume (MPV) chemicals described 
below]. However, a number of environmental 
chemicals that are captured in our analysis are 
food ingredients or naturally occurring human 
metabolites. We included many of the former 
because they are classified as inert ingredients 
in pesticide products.
In this article we address two key aspects 
of this chemical screening and prioritization 
process. The first is the definition of a set of 
chemicals of interest to a screening program, 
based on their widespread use or other poten-
tial for significant human exposure, or the 
current availability of toxicity information 
that can be used in building screening mod-
els. Some widely used but as yet uncharacter-
ized chemicals may not be good candidates 
for screening because their physical–chemical 
properties make them impractical to test in 
in vitro assays (e.g., insoluble or highly vola-
tile compounds), whereas other substances 
that we define as environmental chemicals are 
regarded to be safe under intended use situa-
tions and may not require further testing, but 
can serve as negative controls. For instance, a 
subset of pesticide inert ingredients are also 
on the U.S. Food and Drug Administration 
(FDA) Generally Recognized as Safe chemical 
list. As a further example, some “chemicals” 
that are listed as pesticide inert ingredients are 
common foods, such as milk. 
The second objective is the characterization 
of the sources and amount of reliable in vivo 
toxicology data that can be used for develop-
ing and validating screening models in pro-
grams such as ToxCast. A significant amount 
of high-quality toxicity data are needed to 
train and validate in vitro–based models for 
predicting chemical hazard. Equally important 
is the presence of both negative and positive 
examples for each toxicity end point to be 
modeled. In addition to the sets of environ-
mental chemicals described here, pharmaceuti-
cal compounds are another source of detailed 
animal and human toxicology data.
The sets of chemicals on which we have 
focused are the HPV and MPV chemicals 
from the TSCA inventory, pesticide and anti-
microbial active and inert ingredients, known 
drinking water contaminants, hazardous air 
pollutants (HAPs) and certain defined classes of 
chemicals of interest, including the U.S. EPA’s 
Toxics Release Inventory (TRI), Integrated Risk 
Information System (IRIS), and the first set of 
chemicals to be tested through the Endocrine 
Disruptor Screening Program (EDSP). The 
TRI, drinking water contaminant, and EDSP 
chemicals are largely included in the TSCA 
inventory and pesticide active and inert ingredi-
ent lists. By combining these sources, we define 
a set of 9,912 chemicals. Below we describe in 
detail the process we used to arrive at this num-
ber. At present, we have limited the scope of 
in vivo toxicology data to that which is relevant 
to human health, as opposed to ecotoxicity. An 
equivalent analysis for the ecotoxicity data land-
scape will be carried out in the future.
To support a data-intensive analysis 
of environmental chemicals, we have devel-
oped a system called ACToR (Aggregated 
Computational Toxicology Resource) (Judson 
et al. 2008; U.S. EPA 2008a), which is a data-
base holding essentially all publicly available 
information on chemical identity, structure, 
physical–chemical properties, in vitro assay 
results, and in vivo toxicology data. All of the 
data described in this article have been col-
lected in ACToR.
Target Chemicals for Analysis
The U.S. EPA has authority to review and/or 
regulate a large number of chemicals under 
a variety of statutes, including those govern-
ing the manufacture, import, sale, and use of 
pesticides and industrial chemicals. The large 
numbers of chemicals on various U.S. chemi-
cal inventories, and the limited toxicity infor-
mation for many of these, have already been 
stated as the driver for the need to set priorities 
for additional testing. Because this universe of 
chemicals is so large, it is even necessary to 
prioritize what goes into a science-based pri-
oritization approach such as ToxCast. In this 
article we focus on chemicals that are of inter-
est because a) they are known to be bioactive 
(e.g., pesticide active ingredients), b) they are 
manufactured or used in large quantities (HPV 
and MPV chemicals), or c) many people may 
be exposed to them on a routine basis (e.g., 
drinking water contaminants). We include 
both largely uncharacterized chemicals and 
chemicals for which significant toxicology 
information is already available (e.g., pesti-
cide active ingredients, IRIS chemicals, and 
chemicals on the TRI). The well-characterized 
chemical groups are important because these 
allow us to develop and validate predictive 
models for prioritization of the remaining, 
largely uncharacterized chemicals.
Based on these criteria, we focused on sets 
of chemicals that are defined in the remain-
der of this section. Some of these lists are not 
static, so we have chosen versions available 
as of a specific date. For each of the lists, we 
describe the rules for inclusion and provide 
the total number of chemicals used for the 
current evaluation. “Official” versions of these 
lists are updated and posted to the relevant 
U.S. EPA websites only every 2 or more years, 
so in several cases, we have extracted more 
current snapshots of the lists from internal 
U.S. EPA databases. Many of the chemicals 
we included in this analysis are complex mix-
tures. Additionally, these lists have significant 
overlap; for instance, some pesticide active 
ingredients are also HPV chemicals. Finally, to 
be included in the current ACToR inventory, 
a chemical must be identified by a Chemical 
Abstracts Service Registry Number (CASRN).
Possible later extensions of this analysis 
could consider chemicals with lower produc-
tion volumes or lower exposure potential 
than those considered presently. These would 
include the Canadian Domestic Substances 
List (DSL), which includes approximately 
30,000 chemicals, and the large collection of 
chemicals to be analyzed under the REACH 
program. REACH is still in the process 
of defining its target list, but an estimated 
30,000 chemicals will be included. Many of 
the Canadian DSL and REACH chemicals 
have U.S. use and/or production levels below 
the cutoffs used for the present analysis. Note, 
however, that the Canadian DSL and the 
chemicals we considered here significantly 
overlap. Additionally, pharmaceutical com-
pounds will be included in the future because 
of the corresponding wealth of both animal 
and human toxicology data.
The TSCA Inventory and Inventory Update 
Reporting (IUR). In 1977, the U.S. EPA pub-
lished a rule to assemble an inventory of chemi-
cal substances currently in commerce. This 
inventory, commonly referred to as the TSCA 
Inventory, is the basis for the U.S. EPA’s 
Existing Chemicals Program. Starting in 1986, 
the Inventory was periodically updated using 
the IUR regulation. The TSCA Inventory is 
composed of approximately 85,000 chemical The toxicity data landscape for environmental chemicals
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substances (U.S. EPA 2004b), including both 
substances that are nonconfidential and those 
claimed to be confidential business informa-
tion (CBI) under TSCA. Originally, the IUR 
was updated on a 4-year cycle, but starting 
with the 2006 IUR, it will be updated on a 
5-year cycle. The IUR reporting requirements 
depend on the volume of the chemical that is 
produced as well as certain exemptions. Hence, 
the IUR list is a subset of the larger TSCA 
inventory. Before 2006, the IUR contained 
organic chemicals manufactured or distributed 
in the United States in amounts ≥ 10,000 lb/
year. The 2006 IUR regulation requires manu-
facturers and importers of certain chemical 
substances to report site and manufacturing 
information for chemicals manufactured or 
imported in amounts of ≥ 25,000 lb at a single 
site. Additional information on domestic pro-
cessing and use must be reported for chemicals 
manufactured in amounts of ≥ 300,000 lb at a 
single site. The full inventory, including both 
confidential and nonconfidential substances, 
is maintained by U.S. EPA and Chemical 
Abstract Service and is not available to the 
public. The nonconfidential or “public” inven-
tory is published periodically, usually after each 
IUR cycle. We have included the 2002 version 
of the public TSCA inventory in our analy-
ses. This list is available from the U.S. EPA 
Substance Registry System (U.S. EPA 2008q). 
This list contains 65,513 chemicals indexed by 
CASRN. Note that this number differs from 
the 75,000 quoted elsewhere because this is the 
publicly released list and excludes chemicals 
added under the claim of CBI.
HPV chemicals. The U.S. HPV chemi-
cals are those manufactured in or imported 
into the United States in amounts ≥ 1 million   
lb/year. The U.S. EPA HPV list is fluid, 
changing to some degree with each IUR 
cycle. Our current list contains 2,539 chemi-
cals (U.S. EPA 1990). We also include two 
important subsets of the HPV list.
U.S. EPA HPV Challenge. The HPV 
Challenge Program chemical list consists of all 
the HPV chemicals reported during the 1990 
IUR reporting year. Inorganic chemicals and 
polymers, except in special circumstances, were 
not included in the HPV Challenge Program. 
Our version of the HPV Challenge list con-
tains 1,973 chemicals (U.S. EPA 1990).
U.S. EPA HPV information system. These 
are chemicals with data submitted under the 
HPV Challenge Program for which “Robust 
Summary” data have been entered into the 
U.S. EPA HPV information system (HPVIS; 
U.S. EPA 2008l). There are 991 chemicals 
from HPVIS with information in ACToR.
MPV chemicals. Another set of industrial 
chemicals of interest are the non-HPV chemi-
cals included in the TSCA IUR list. These are 
the chemicals exceeding a reporting threshold 
of 10,000 lb/year before 2006, and 25,000 lb in 
2006 and beyond, but < 1 million lb/year. The 
2002 IUR list contains 5,375 MPV chemi-
cals (U.S. EPA 2004a, 2004b). The updated, 
draft 2006 IUR list contains approximately 
3,668 MPV chemicals that are not CBI; the 
2006 IUR public list will be released by the 
U.S. EPA in 2009.
Pesticides and antimicrobials. This 
cate  gory covers a wide range of substances. 
Chemicals regulated as part of the U.S. EPA 
pesticide program are generally classified as 
“active” or “inert.” The active ingredients 
are further classified by whether they are tar-
geted at microbes (antimicrobials) or complex 
organisms (pesticides). Additionally, all pesti-
cide compounds (conventional actives, anti-
microbials, and inert ingredients) are classi  fied 
by whether or not they have food-use toler-
ances or tolerance exemptions. Finally, one 
can classify these chemicals by whether or not 
they are in use in significant quantities. Here 
we rely on the Office of Pesticide Products 
Information (OPPIN) system of the U.S. 
EPA to extract lists of chemicals. OPPIN is 
not publically accessible. From this, we have 
drawn the following subsets:
•	Conventional	Pesticide	Actives: (EPA 
OPPIN pesticide active): active pesticide 
ingredients (834 chemicals)
•	Antimicrobial Actives (EPA OPPIN anti-
microbial active): active ingredients used 
against microbes (337 chemicals)
•	Pesticide inert ingredients: an inert ingre-
dient means any substance, other than 
an active ingredient, that is intentionally 
included in a pesticide product. Inert ingre-
dients have a number of uses, for instance, 
as a solvent, as an aid in increasing the pes-
ticide product’s shelf life, or as an agent 
to protect the pesticide from degradation 
due to exposure to sunlight. We used two 
sources: a) U.S. EPA OPPIN inert ingredi-
ents (the complete OPPIN list containing 
3,532 chemicals); and b) U.S. EPA inert 
nonfood ingredients [a list of inert pesticide 
ingredients classified by hazard potential, 
not approved for food contact use, avail-
able from the U.S. EPA’s Office of Pesticide 
Programs (OPP) website (3,492 chemicals) 
(U.S. EPA 2008n)]
•	Pesticide ingredients with food-use toler-
ances or tolerance exemptions (U.S. EPA 
OPPIN food use) (1,320 chemicals)
U.S. EPA TRI. The Emergency Planning 
and Community Right-to-Know Act of 1986 
(EPCRA 1986) requires businesses to report the 
locations and quantities of chemicals stored on-
site to state and local governments in order to 
help communities prepare to respond to chem-
ical spills and similar emergencies. EPCRA 
requires U.S. EPA and the states to annually 
collect data on releases and transfers of certain 
toxic chemicals from industrial facilities, and 
to make the data available to the public in the 
TRI. In 1990 Congress passed the Pollution 
Prevention Act of 1990 (Pollution Prevention 
Act 1990), which requires that additional data 
on waste management and source reduction 
activities be reported under the TRI. The U.S. 
EPA compiles the TRI data each year and 
makes these data available through several data 
access tools, including their website (U.S. EPA 
2008p). Our analysis includes 636 chemicals 
from TRI.
Drinking water contaminants. The U.S. 
EPA develops drinking water standards and 
identifies lists of potential drinking water con-
taminants because they are anticipated to occur 
in drinking water supplies and may have adverse 
health effects. The lists tracked in the present 
analysis are the U.S. EPA’s Drinking Water 
Standards and Health Advisory Chemicals 
(DWSHA; 200 chemicals) and the Candidate 
Chemical Lists [CCLs: U.S. EPA CCL1, U.S. 
EPA CCL2, and U.S. EPA draft CCL3, which 
include 47, 39, and 92 chemicals, respectively 
(U.S. EPA 2008e)]. We also included the 
Preliminary CCL (PCCL) listing of the 528 
chemicals that the U.S. EPA evaluated during 
the development of draft CCL3 (U.S. EPA 
2008d). The U.S. EPA PCCL was derived from 
a collection of approximately 6,000 chemicals 
analyzed by the U.S. EPA’s Office of Water, 
and the PCCL was selected from these 6,000 
chemicals based on available health effects and 
occurrence data (U.S. EPA 2008c).
U.S. EPA Great Lakes National Program 
Office. A set of 429 candidate persistent, bioac-
cumulative toxicants (PBTs) compiled by the 
U.S. EPA Great Lakes National Program Office 
(GLNPO) are included in the present analysis 
(Muir and Howard 2006). These are designated 
as U.S. EPA GLNPO PBT chemicals.
U.S. EPA HAPs. This is a list of chemi-
cals that are under review by the U.S. EPA 
specified in the Clean Air Act Amendments of 
1990. These chemicals include volatile organic 
chemicals, chemicals used as pesticides and 
herbicides, inorganic chemicals, and radionu-
clides. Many of these chemicals are used for a 
variety of purposes in the United States today. 
Other chemicals, although not in use today, 
were used extensively in the past and may still 
be found in the environment. We include a 
total of 185 chemicals from this source.
EDSP chemicals. A variety of chemicals 
have been found to disrupt the endocrine 
systems of animals in laboratory studies, and 
compelling evidence shows that endocrine 
systems of certain fish and wildlife have been 
affected by chemical contaminants, resulting 
in developmental and reproductive problems. 
Based on this and other evidence, Congress 
passed the Food Quality Protection Act of 
1996, which requires that the U.S. EPA test 
for the potential estrogenic effects in humans. 
Subsequently, a U.S. EPA advisory committee 
recommended that this be expanded to include Judson et al.
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effects occurring via androgen and thyroid 
mechanisms and potential for effects on eco-
logic species. We have included the 73 chemi-
cals that were listed to be screened under Tier 1 
of the U.S. EPA EDSP (U.S. EPA 2007a).
ToxCast phase I chemicals. ToxCast is a 
U.S. EPA program designed to apply HTS, 
high-content screening and genomics tech-
niques to the screening and prioritization of 
environmental chemicals (Dix et al. 2007). 
Phase I of this program is screening 309 
unique chemicals, most of which are pesti-
cide active ingredients. (One of the ToxCast 
chemicals has no CASRN, so we do not 
include it in the analyses below.) This chemi-
cal listing is available for download from the 
ToxCast or U.S. EPA Distributed Structure-
Searchable Toxicity Data Network (DSSTox) 
websites (U.S. EPA 2008k, 2008o).
Toxicology Reference Database. This is 
a collection of summary in vivo toxicology 
data, currently focused on pesticide active 
ingredients. Data on pesticide actives is col-
lected and summarized from U.S. EPA OPP 
data evaluation records (DERs), which are 
summaries of guideline studies required 
before approval of new pesticide active ingre-
dients. The Toxicology Reference Database 
(ToxRefDB) provides the toxicology data 
required to link in vitro assays from ToxCast 
with in vivo toxicity end points (Martin et al. 
2008). ToxRefDB will eventually contain 
information on most of the pesticide active 
chemicals of ToxCast phase I and will later 
expand to include toxicity data on additional 
pesticide and nonpesticide chemicals. The 
current database contains information on 431 
chemicals. In addition to data derived from 
pesticide DERs, ToxRefDB will contain data 
from other primary in vivo toxicology sources.
U.S. EPA Integrated Risk Information 
System. The collection of chemicals subject to 
evaluation by the U.S. EPA Integrated Risk 
Information System (IRIS) program make up 
three major lists: the main U.S. EPA IRIS set 
(U.S. EPA 2008f), for which evaluations are 
currently available (535 chemicals); the U.S. 
EPA IRIS nominations (U.S. EPA 2008g; 
currently 20 chemicals nominated for inclu-
sion); and the U.S. EPA IRIS queue (U.S. 
EPA 2008h), which are chemicals in queue to 
have IRIS reports written (68 chemicals).
Target collection summary. The total 
number of chemicals (defined by unique 
CASRN) in this set of collections comes to 
9,912. Table 1 shows the overlap matrix 
between these target chemical lists. The sum 
of the number of chemicals in the individual 
lists is 23,985. This number drops to 9,912 
once we remove overlaps. For instance, 720 
chemicals are on the U.S. EPA HPV and on 
the U.S. EPA OPPIN inert ingredients lists. 
From the U.S. EPA CCL3 list, 29 of 92 are 
also HPV chemicals. Interestingly, in a few 
cases no overlap occurs between pairs of lists. 
Two instances are the lack of overlap between 
the U.S. EPA CCL1 and CCL2 lists and the 
U.S. EPA GLNPO PBT list.
Information Sources
The information that is available on the target 
chemicals can be divided into several assay 
categories. The sources for each of these types 
of data are available online at http://www.epa.
gov/ncct/toxcast/.
Table 1. Numbers of chemicals that overlap between the screening target chemical collections.
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EPA CCL1 47 47 39 13 34 25 6 0 14 11 11 4 31 2 7 14 15 5 14 8 6 27 11 16
EPA CCL2 39 39 39 13 28 19 5 0 12 10 10 4 25 1 5 13 13 4 13 7 5 22 10 15
EPA draft CCL3 92 13 13 92 92 19 9 2 28 29 30 8 56 1 10 39 31 11 41 19 10 60 25 31
EPA PCCL 528 34 28 92 528 62 33 21 77 237 259 91 187 6 27 302 125 52 166 162 135 206 73 93
EPA DWSHA 200 25 19 19 62 200 29 4 69 61 60 26 176 6 40 77 63 23 69 55 33 130 43 59
EPA EDSP 73 73 6 5 9 33 29 73 1 12 8 11 6 57 1 3 12 64 15 66 15 12 44 56 66
EPA GLNPO PBT 429 0 0 2 21 4 1 429 8 109 75 37 22 2 4 194 3 2 12 43 39 20 4 7
EPA HAPs 185 14 12 28 77 69 12 8 185 92 101 27 144 3 36 122 24 15 43 68 43 173 15 21
EPA HPV 2,539 11 10 29 237 61 8 109 92 2,539 1,746 701 145 11 34 2,187 102 84 246 720 676 162 13 28
EPA HPV Challenge 1,973 11 10 30 259 60 11 75 101 1,746 1,973 703 147 10 37 1,759 77 60 212 612 567 166 11 25
EPA HPVIS 992 4 4 8 91 26 6 37 27 701 703 992 54 6 12 747 37 34 81 268 250 58 8 15
EPA IRIS 535 31 25 56 187 176 57 22 144 145 147 54 535 10 50 183 179 42 187 115 75 290 122 147
EPA IRIS nominations 20 2 1 1 6 6 1 2 3 11 10 6 10 20 0 13 2 2 4 6 5 9 1 2
EPA IRIS queue 68 7 5 10 27 40 3 4 36 34 37 12 50 0 68 46 8 8 10 31 18 46 2 4
EPA IUR (2002) 5,375 14 13 39 302 77 12 194 122 2,187 1,759 747 183 13 46 5,375 151 140 378 1,195 1,126 230 23 47
EPA OPPIN pesticide active 834 15 13 31 125 63 64 3 24 102 77 37 179 2 8 151 834 217 484 178 169 175 272 363
EPA OPPIN antimicrobial active 337 5 4 11 52 23 15 2 15 84 60 34 42 2 8 140 217 337 129 155 151 57 33 63
EPA OPPIN food use 1,320 14 13 41 166 69 66 12 43 246 212 81 187 4 10 378 484 129 1,320 744 724 169 239 300
EPA OPPIN inerts 3,532 8 7 19 162 55 15 43 68 720 612 268 115 6 31 1,195 178 155 744 3,532 3,183 136 22 35
EPA inerts nonfood 3,492 6 5 10 135 33 12 39 43 676 567 250 75 5 18 1,126 169 151 724 3,183 3,492 92 15 26
EPA TRI 636 27 22 60 206 130 44 20 173 162 166 58 290 9 46 230 175 57 169 136 92 636 112 144
ToxCast phase I 308 11 10 25 73 43 56 4 15 13 11 8 122 1 2 23 272 33 239 22 15 112 308 304
ToxRefDB 431 16 15 31 93 59 66 7 21 28 25 15 147 2 4 47 363 63 300 35 26 144 304 431The toxicity data landscape for environmental chemicals
Environmental Health Perspectives  •  v o l u m e  117 | n u m b e r 5 | May 2009  689
Chemical structures. We have compiled 
structures for most of the defined compounds 
(as opposed to mixtures) in the target lists. 
For subsets of chemicals, structures have been 
hand curated and quality reviewed as part 
of the U.S. EPA DSSTox program (Richard 
et al. 2008). We took the remaining structures 
from a variety of sources, including PubChem 
[National  Center  for  Biotechnology 
Information (NCBI) 2008], the National 
Cancer Institute’s Chemical Structure Lookup 
Service (National Cancer Institute 2008), 
and the U.S. EPA Substance Registry System 
inventory. In many cases, structures were 
derived from Simplified Molecular Input Line 
Entry Specification (SMILES) codes (Daylight 
Chemical Information Systems, Inc. 2008). 
At present, we have chemical structures for 
7,099 of the 9,912 target chemicals. We lack 
structure information for many chemicals 
because many substances on these lists are 
mixtures, sometimes relatively simple ones 
for which representative structures could be 
designated (e.g., “sulfuric acid, mono-C14–18-
alkyl esters, sodium salts”), and sometimes 
very complex mixtures (agar, sesame oil).
Physical–chemical properties. We used 
U.S. EPA’s EPISuite (U.S. EPA 2007c) set 
of programs to calculate physical–chemical 
properties for a subset of chemicals. The 
input to EPISuite is a list of SMILES codes. 
Several EPISuite programs were used includ-
ing KOWWIN [estimates the logarithmic 
octanol–water partition coefficient (logP, 
also sometimes called log Kow) of organic 
compounds (Meylan and Howard 1995)], 
MPBPWIN [estimates the boiling point (at 
760 mm Hg), melting point, and vapor pres-
sure of organic compounds (Stein and Brown 
1994)], WATERNT (estimates the water solu-
bility of organic compounds at 25°C; Meylan 
and Howard 1995), and WSKOWWIN 
(estimates the water solubility of an organic 
compound using the compounds log octanol–
water partition coefficient; Meylan et al. 
1996). The properties we use are molecular 
weight (MW), logP, boiling point, melting 
point, vapor pressure, phase at 25°C, and 
molar water solubility. EPISuite reports (and 
we) use experimental values when available.
Biochemical (in vitro or cell-based) assay 
data. For a subset of the chemicals of inter-
est, in vitro (biochemical) or cell-based assay 
data are currently available. This can include 
receptor binding, enzyme inhibition, or 
cytotoxicity. The major sources of these data 
are PubChem and the National Institute of 
Mental Health’s Psychoactive Drug Screening 
Program Ki Database (Roth and Lopez 2008).
In vivo toxicology assay data (tabular). We 
derived these data from guideline (or equiva-
lent) toxicology studies from which the pri-
mary or secondary data are available. For our 
purposes, the main sources of this primary data 
are the National Toxicology Program (NTP), 
U.S. EPA OPP (through ToxRefDB; Martin 
et al. 2008), the U.S. EPA’s HPVIS, and the 
FDA. The FDA data we used here came from 
the following databases: a) FDA Generally 
Recognized as Safe list; b) FDA Cumulative 
Estimated Daily Intake/Acceptable Daily 
Intake Database; c) FDA Everything Added 
to Food in the United States database; and 
the d) FDA List of “Indirect” Additives Used 
in Food Contact Substances. We compiled 
our tabular primary data largely through the 
ToxRefDB database (Martin et al. 2008) and 
the DSSTox programs (Richard et al. 2006). 
HPVIS is a special case because it includes 
both primary and secondary data, often pro-
vided in summary by sponsors, with data 
derived either from the open literature or 
from sponsor-derived study reports. The data-
base captures so-called “Robust Summaries.” 
Examples of secondary tabular in vivo tox-
icity data are the Carcinogenic Potency 
Database (Gold et al. 2001), U.S. EPA IRIS 
reports, National Library of Medicine (NLM) 
TOXNET databases (Hazardous Substances 
Data Bank and Chemical Carcinogenesis 
Research Information System), and California 
EPA. Data from a number of these secondary 
sources have been tabulated and made avail-
able through the DSSTox program (Richard 
et al. 2007). Types of tabular information that 
are captured in the DSSTox program include 
high-level summary results such as food-use 
tolerances, LOAELs and NOAELs (lowest 
and no observed adverse effect levels), and 
reference doses, as well as highly detailed data 
such as the per-animal or group-level results of 
toxicology studies. Cell-based genotoxicity is 
currently captured under this category because 
it co-occurs with rodent carcinogenicity data 
in current ACToR data sources.
In vivo toxicology text reports via URL. 
Much of the publicly available in vivo toxi-
cology data are in the form of narrative 
reports from which detailed tabular data may 
or may not have been extracted. Examples 
are the original NTP, IRIS, and Screening 
Information Data Sets (SIDS) reports, the 
latter from the Organization for Economic 
Cooperation and Development (OECD) 
HPV Programme. We also included the 
International Agency for Research on Cancer 
(IARC) and Agency for Toxic Substances and 
Disease Registry (ATSDR) study reports in 
this set. These reports contain quantitative and 
categorical data, but for most of these sources, 
the data provided are not easily extractable. 
All of the studies we used here are accessible 
via the Web. Information can be extracted 
from these reports on a case-by-case basis.
In vivo toxicology summary calls. Several 
sources have made definitive calls concerning 
particular modes of toxicity, for instance, label-
ing chemicals as being human carcinogens or 
developmental toxicants. These calls are made 
by experts using data from the detailed toxicity 
reports described previously. Although the calls 
are subject to debate by experts, they provide 
a useful source of data for training prioritiza-
tion models. This information is typically cate-
gorical. Examples of summary calls are cancer 
potential determinations of the California EPA 
(2008), the NTP Report on Carcinogens (NTP 
2008b), NTP Center for the Evaluation of 
Risks to Human Reproduction (NTP 2008a), 
and the U.S. EPA OPP cancer classifications 
(U.S. EPA 2007b).
Regulatory listings. By law, the U.S. EPA 
and some state agencies maintain a number 
of lists of chemicals that are of toxicologic 
concern. The presence of a chemical on one of 
these lists indicates that toxicity data are avail-
able. For the present analysis, we derived these 
lists from the U.S. EPA Substance Registry 
System (U.S. EPA 2008j).
Phenotypes. Above we have described the 
information types of the data rather than the 
disease or toxicology categories. Where pos-
sible, assays or data sources have also been 
labeled by appropriate disease or toxicology 
categories, and we label these categories as 
“phenotypes.” The set of phenotypes imple-
mented in ACToR span traditional toxicology 
study areas. The subset of phenotypes we use 
here are general hazard, carcinogenicity, geno-
toxicity, developmental toxicity, reproductive 
toxicity, and chronic toxicity. Other toxic-
ity phenotypes are represented in ACToR, 
but for small numbers of chemicals. Many 
data sources, especially the toxicology sum-
mary reports, contain information on mul-
tiple types of toxicity or end points. In this 
category, we have included only IRIS, NTP, 
ToxRefDB, and U.S. EPA and OECD HPV 
SIDS reports because they can be assumed to 
have covered a defined standard set of areas 
of toxicity for most chemicals. “Hazard” is 
a very broad phenotype category that can 
include assays derived from acute and sub-
chronic rodent studies at one end or material 
safety data sheets at the other. We further 
track information on food safety assessments, 
as provided by the FDA (FDA 2006, 2007, 
2008). In addition, the U.S. EPA sets food-
use tolerances (or tolerance exemptions) for 
a subset of pesticide ingredients. There is a 
significant overlap between chemicals regu-
lated by the U.S. EPA and those analyzed by 
the FDA. It is obviously of great value to have 
both positive and negative toxicity informa-
tion for all of the phenotypes, and both types 
were captured where they were available.
Several reviews of the toxicology data land-
scape have described sources of data that are 
included in ACToR. Yang et al. (2006a, 2006b) 
have recently published two such reviews. In 
2001 and 2002, several review papers were 
published surveying the landscape of toxicity Judson et al.
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data available on the Internet (Brinkhuis 2001; 
Felsot 2002; Junghans et al. 2002; Patterson 
et al. 2002; Polifka and Faustman 2002; Poore 
et al. 2001; Richard and Williams 2003; 
Russom 2002; Winter 2002; Wolfgang and 
Johnson 2002; Young 2002).
We provide a summary of the sources 
of toxicology data we used in this analysis, 
available online at http://www.epa.gov/ncct/
toxcast/. In the simplest case, each toxicology 
source is a single assay in the ACToR database. 
(There are multiple exceptions; e.g., DSSTox 
and NTP each contribute multiple assays.) For 
each assay, we list the short name, a descrip-
tion, the institutional source, the number of 
chemicals covered, the types of information 
provided, and a URL. There were 22 sources 
from which target screening chemicals were 
taken, 47 sources of toxicology data, and 
48 lists of chemicals covered by regulations.
Data Collection and 
Integration: ACToR
All of the data for this analysis are collected 
in the ACToR system (Judson et al. 2008; 
U.S. EPA 2008a). The organizing principles 
for the design of the chemical/assay system 
are largely derived from the PubChem proj-
ect, which captures chemical structure and 
HTS information on millions of chemicals 
in its role as the main data repository for the 
NIH Molecular Libraries Roadmap (Austin 
et al. 2004). PubChem characterizes data 
in terms of “substances” (the actual chemi-
cal on which one performs an experiment as 
defined by the data source), “compounds” 
(the idealized structures of chemicals), and 
assays (data generated on substances). ACToR 
collects these same three main types of data: 
substances, indexed by substance identifier 
(called the SID); compounds (i.e., chemi-
cal structures) indexed by compound iden-
tifier (called the CID); and assays, indexed 
by assay identifier (called the AID). A sub-
stance is a single chemical entity from one 
data source and often corresponds to the 
physical substance on which some experiment 
was performed. A compound is a chemical 
entity that corresponds to a unique chemical 
structure. Because a substance is defined as 
being specific to both data source and experi-
ment, many substances (SIDs) may map to a 
single compound (CID). An assay, indexed 
by AID, represents a specific type of test data 
associated with one or more substances. In 
ACToR, a substance is minimally charac-
terized by a data-collection–specific SID 
and a chemical name. Most often, the sub-
stance will also have synonyms, a CASRN, 
and several other parameters. A compound 
always has an associated chemical structure 
and a data-collection–specific CID, in addi-
tion to optional parameters derived directly 
from chemical structures, such as SMILES 
(Daylight Chemical Information Systems, Inc. 
2008) and International Chemical Identifier 
[International Union of Pure and Applied 
Chemistry (IUPAC) 2008)] linear chemi-
cal structure representations and MW. Note 
that because ACToR is in essence a “super-
aggregator,” pulling in large external data col-
lections, it also stores the source-labeled SIDs 
and CIDs from each independent collection 
(e.g., PubChem CID, DSSTox CID).
In ACToR, as in DSSTox, data on chemi-
cals across data collections are aggregated 
using the concept of a generic chemical. 
Because most environmental chemicals, along 
with their related toxicity data, are indexed by 
CASRN, which can be thought of as a source-
independent test SID, ACToR aggregates 
information based on this identifier. A generic 
chemical is defined by a CASRN, a preferred 
name (typically a common name rather than 
an IUPAC or other systematic name), and 
an optional ACToR CID. Some sources (in 
particular, the FDA and NTP) have provided 
CASRN-like identifiers for some compounds, 
and these are used in ACToR in place of the 
CASRN. All data on all substances sharing 
a particular CASRN are attached to the cor-
responding generic chemical. In particular, 
a generic chemical will inherit all names 
attached to substances with the corresponding 
CASRN as synonyms.
In ACToR, an assay is a generic collec-
tion of data values associated with a set of 
substances and (potentially) compounds (i.e., 
chemical structures). An assay has a unique 
AID, a name, an assay category, and, option-
ally, one or more “phenotypes.” Table 2 lists 
the assay categories (major types of assays). 
Assay phenotypes are linked to high-level 
classes of toxicity testing such as carcino-
genicity or reproductive or developmental 
toxicology. This allows quick searching of the 
database to find all assays that pertain to that 
high-level toxicology concept. The concept of 
an assay as implemented in ACToR is pur-
posely broad so as to capture any information 
potentially relevant to understanding toxicity 
and evaluating risk for environmental chemi-
cals. An assay can also have one or more com-
ponents, which are separate data fields that 
naturally fall together into an assay (e.g., the 
binding constant to a receptor at different 
concentrations). Each component is defined 
by an assay component identifier, the cor-
responding AID, a name, a description, units 
(when applicable), and a data type (float, inte-
ger, categorical, text, Boolean, URL). The 
actual data values are called assay results and 
are linked to the assay, the assay component, 
and the original data-collection–specific sub-
stance. All of the data for an assay can be rep-
resented as a table with one row per chemical 
and one column per assay component.
To be included in ACToR, a data source 
must meet several criteria: a) data must be 
publicly available; b) information sources 
must have a significant overlap with chemicals 
of interest; c) information must be indexed by 
chemical, that is, available on a chemical-by-
chemical basis; and d) information must be 
indexed by CASRN (although data are also 
included for substances having no assigned 
CASRN). We do not require that data be peer 
reviewed, although for the analysis we report 
Table 2. Categories of assays in ACToR that are described in this analysis.
Assay category  Description  Examples
Physical–chemical  Physical and chemical properties (in vitro and/or in silico)  MW
      LogP
    Boiling point
Biochemical  Biochemical (non-cell-based) (in vitro and/or in silico)  Enzyme inhibition constants
      Receptor binding constants
In vivo toxicology (tabular)  Tabulated results from primary or secondary animal-based  Clinical chemistry
    studies of chemical effect  Histopathology
In vivo toxicology (study listing primary)  Primary studies are available but have not been tabulated  Clinical chemistry
    Histopathology
    Developmental and reproductive assays
In vivo toxicology (summary calls)  Derived summary determinations of risk  Chemicals determined to pose a 
      defined risk of human cancer
In vivo toxicology (summary report via URL)  Links to text reports on the Web for which specific data values  Reports from U.S. EPA IRIS or NTP
    are not directly accessible in tabular form
Regulatory  Listings of chemicals that fall under specific environmental laws  TSCA 
    or government mandates The toxicity data landscape for environmental chemicals
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here, most of the data sources either have been 
externally peer reviewed or, when from gov-
ernment agencies, have undergone extensive 
internal review. Data entered into ACToR 
undergo a limited quality control process. 
Data are preferably taken from sources of 
high-quality data, so our quality control is 
limited to checking that the data are correctly 
transferred from the source via a reformatting 
and loading process into the ACToR data-
base. No checks are made on the correctness 
of the data from the original source. Each data 
set is manually spot-checked for gross issues 
with reformatting. All CASRNs in the data-
base are checked to be sure that they have a 
proper checksum (Chemical Abstracts Service 
2008). (The checksum is the result of a par-
ticular formula performed on all but the final 
digit of the CASRN. This result must match 
the final digit.) All data-handling tasks are 
documented in standard operating procedures 
to ensure consistency.
The ACToR database is implemented using 
MySQL. Software to preprocess and load data 
is written in Perl, and the Web interfaces are 
written in Java. The use of 100% open-source 
software allows the entire system to be easily 
distributed to other interested groups. We used 
the ACToR database version 2008Q2d for 
all of the analyses in this article. Of the sub-
sets of data sources in ACToR, only the ones 
most relevant to toxicology are included in this 
analysis and publication. ACToR is available 
online (http://actor.epa.gov).
Results
In vivo toxicology data. This section describes 
the overlap between the target chemical set 
and the set of toxicity data sources. Table 3 
summarizes the overlap matrix. Each cell 
provides the number and the percentage of 
the 9,912 for the chemicals that have infor-
mation for a specific category of data (e.g., 
tabular) and a particular phenotype (e.g., 
carcinogenicity). The last column gives the 
number and percentage of chemicals for each 
phenotype, regardless of the information cate-
gory. Chemicals are only counted once in any 
cell, even if they have multiple data points or 
sources of data. Cells that list 0 indicate that 
there were no corresponding data from any 
source. The available toxicity data almost all 
derive from animal studies, because essentially 
no experimental human data are available. 
However, some of the data are in the form 
of human reference doses, or summary calls 
of the form “this chemical is considered to 
be a human carcinogen.” These data points 
were, of course, derived by extrapolating from 
primary data on animals. Chemical hazard 
has been evaluated for 5,810 (58.6%) of these 
chemicals. Carcinogenicity potential for 2,579 
(26%) of these chemicals has been evaluated 
by at least one source. The genotoxic poten-
tial of 2,724 (27.5%) of the chemicals has 
been evaluated. A total of 2,862 (28.9%) of 
the chemicals have their developmental toxic-
ity reported, and 1,081 (10.9%) have repro-
ductive toxicity data reported. Food safety 
information (from one of the sources men-
tioned above) is available for 2,258 (22.8%) 
of the chemicals. Chemicals count in this table 
whether they have positive or negative data for 
toxicity for a particular phenotype. To date, 
we have not systematically tabulated the rela-
tive number of toxic and nontoxic indications 
for all chemicals.
Table 4 provides overlaps of the chemicals 
of interest with more general information and 
biological assays of potential interest. One or 
more in vitro biochemical assays are available 
for 781 (7.9%) of the chemicals. Most of these 
are in vitro cytotoxicity assays in PubChem, 
but also include receptor binding and enzyme 
inhibition data. A small number of the target 
chemicals (234 or 2.4%) are naturally occur-
ring human metabolites, based on data from 
the Human Metabolome Database (Wishart 
et al. 2007).
The highest-quality toxicity assessments, 
based on guideline studies or on extensive 
review of the literature, are U.S. EPA OPP 
reviews (which are captured in the ToxRefDB 
database), U.S. EPA IRIS assessments, NTP 
studies, OECD SIDS guideline studies of HPV 
chemicals, studies in the U.S. EPA HPVIS, 
and assessments by the ATSDR and IARC. 
From the current list, there are 431 (4.3%), 
536 (5.4%), 1,168 (11.8%), 343 (3.5%), 
992 (10%), 216 (2.2%), and 537 (5.4%) 
chemicals in these respective sets (Table 4). 
Looking across all of these data sources, 2,767 
(27.9%) are covered by one or more of these 
high-quality toxicology sources. Finally, a total 
of 4,641 (46.8%) are currently subject to one 
or more U.S. EPA regulations. These regula-
tions are available online (http://www.epa.gov/
ncct/toxcast/).
Chemical categories. Both the U.S. HPV 
Challenge and the OECD HPV programs 
encourage the use of categories because of 
the large number of chemicals being assessed. 
Using a category approach, chemicals are evalu-
ated as a group, or category, rather than as indi-
vidual chemicals, and not every chemical needs 
to be tested for every end point. The category 
approach entails grouping chemicals with simi-
lar structures, physical–chemical properties, fate 
parameters, and toxicologic properties in order 
to extrapolate toxicologic information from 
tested chemicals and end points to untested 
chemicals and end points. For most categories, 
the number of chemicals with toxicology data 
that could be used for model building is much 
smaller than the total number of chemicals 
included within the category.
ACToR includes listings of chemical cat-
egories taken from the U.S. EPA HPVIS and 
from the OECD HPV Programme. From these 
lists, a total of 1,274 (12.9%) chemicals are in 
at least one category, and there are 256 unique 
categories that include at least one of the target 
chemicals. However, most of the categories in 
HPVIS represent “proposals,” which are cur-
rently under review by the U.S. EPA, such that 
the final number of categories and chemicals 
assigned to them is subject to change. In addi-
tion, the U.S. EPA is currently using chemical 
clustering techniques with the goal of creating 
chemical categories to facilitate hazard assess-
ment of MPV chemicals. The outcome of these 
efforts will be included in ACToR in the future. 
Information will also flow in the opposite direc-
tion; that is, the data and information included 
in ACToR will be useful in reviewing and refin-
ing the U.S. EPA’s HPV and MPV categories.
Production volumes. An important com-
ponent of any prioritization program will be 
Table 3. Summary of overlap between the target chemical list and the set of assay components.
    Primary    Summary
Assay  Tabular  study listing  Summary calls  report via URL  Any
Hazard  4,454 (44.9)  0  255 (2.6)  4,767 (48.1)  5,810 (58.6)
Carcinogenicity  1,211 (12.2)  401 (4.0)  726 (7.3)  2,035 (23.3)  2,579 (26)
Genotoxicity  2,496 (25.2)  1,102 (11.1)  32 (0.3)  1,047 (10.6)  2,724 (27.5)
Developmental toxicity  755 (7.6)  37 (0.4)  125 (1.3)  2,324 (23.4)  2,862 (28.9)
Reproductive toxicity  734 (7.4)  0  31 (0.3)  396 (4)  1,081 (10.9)
Food safety  1,692 (17.1)  0  533 (5.4)  0  2,258 (22.8)
Each cell provides the number and the percentage of the 9,912 for the chemicals that have information for a specific 
category of data (e.g., tabular) and a particular phenotype (e.g., carcinogenicity). The last column gives the number and 
percentage of chemicals for each phenotype, regardless of the information category. Chemicals are only counted once in 
any cell, even if they have multiple data points or sources of data. Cells with 0 indicate that there were no corresponding 
data from any source.
Table 4. Coverage by specific data types and 
sources.
Name  Total  Percent coverage
Biochemical  781  7.9
Human-metabolite  234  2.4
ToxRefDB  431  4.3
IRIS  536  5.4
NTP  1,168  11.8
SIDS  343  3.5
HPVIS  992  10.0
ATSDR  216  2.2
IARC  537  5.4
ToxRefDB, IRIS, NTP,   2,767  27.9
  SIDS, ATSDR, 
  and/or IARC 
Regulation  4,641  46.8Judson et al.
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an assessment of potential for exposure. In 
the absence of specific information and for 
screening and prioritization purposes, produc-
tion volumes are often used as a surrogate for 
exposure potential. Table 5 lists counts for 
each of the production volume categories. A 
total of 5,939 (59.9%) of the target chemicals 
have production volume information in the 
2002 IUR.
Properties related to chemical structure. 
Physical–chemical properties were calculated 
using the EPISuite collection of programs, 
which use chemical structure (in the form of a 
SMILES string) as input. Of the 7,099 chemi-
cals for which structures and SMILES data 
were available, EPISuite was able to process 
5,857. The chemicals for which calculations 
could not be performed were mainly certain 
types of salts, inorganic compounds, organo-
metallics, or chemicals with nonstandard 
SMILES.
Several parameters will be useful for deter-
mining whether a compound can be bioavail-
able or whether it will be amenable to HTS 
assays: MW, logP, solubility, and vapor pres-
sure. Typical ranges for properties for chemi-
cals that can be tested using HTS methods are 
MW < 500 Da, logP between 0 and 6, and 
vapor pressure < 10 mm (not volatile at room 
temperature). Filtering the larger list against 
this set of criteria yields a set of 3,060 com-
pounds that are candidates for HTS testing. 
One could produce slightly different lists, of 
course, by altering these threshold values. The 
primary requirements for use in an HTS assay 
are that chemicals be soluble in dimethyl sul-
foxide or water, that they be nonvolatile, and 
that they be stable in solution.
Figures 1 and 2 show distributions of 
MW and logP for the complete set of chemi-
cals with structures and for four representative 
subsets of the larger data collection: HPV 
chemicals, pesticide inert ingredients, pesti-
cide active ingredients, and the ToxCast phase 
I collection. For MW, the main trend is that 
the HPV and pesticide inert collections con-
tain significantly larger fractions of low-MW 
chemicals (< 200 Da) than do the pesticide 
active ingredients and the ToxCast chemi-
cals. Given that most ToxCast phase I chemi-
cals are pesticide active ingredients and that 
this set was prefiltered for HTS suitability, 
it is not surprising that this set has a smaller 
fraction of high-MW chemicals (> 500 Da) 
than do the other collections. Distributions 
of logP are similar for all of the subsets except 
for ToxCast, which is more tightly clustered, 
with a peak between 0 and 2.
Discussion
In this article we describe and analyze a com-
pilation of chemical structures, physical–
chemical properties, in vitro biochemical assay 
data, and in vivo toxicology data on a large 
collection of chemicals of interest to the U.S. 
EPA. Most of these data are currently pub-
licly available but have not been organized 
previously in a unified manner that allows 
for the analysis of large trends and simplified 
review based on either chemical or assay axes. 
The data we describe here are a subset of those 
contained in the ACToR system being devel-
oped at the U.S. EPA to manage large collec-
tions of data on environmental chemicals.
We have used the ACToR database to 
characterize the state of toxicologic knowl-
edge on a subset of environmental chemicals 
that are on a variety of lists of interest to the 
U.S. EPA. This analysis is used to address the 
extent of the perceived data gap on potentially 
toxic chemicals. Although the picture is com-
plicated, some summary observations are pos-
sible. About two-thirds of the chemicals have 
some toxicology information. The unique set 
of chemicals in Table 3 is 6,551 of 9,912 
(66%). The alternative view is that many of 
these chemicals remain largely uncharacter-
ized—a total of 3,361 (34%) chemicals have 
no information in any of the data sources we 
used in this analysis. On the other hand, more 
than one-quarter (27.9%) have been analyzed 
in one or more high-quality and/or systematic 
evaluation programs (NTP, IRIS, ToxRefDB, 
U.S. EPA HPV, OECD SIDS, IARC, and/
or ATSDR). Of the individual types of toxic-
ity (or end points) that have been tabulated, 
carcino  genicity, genotoxicity, and develop-
mental and reproductive toxicity have been 
most widely covered (26%, 27.5%, 28.9%, 
and 10.9%, respectively).
One immediate application of this analysis 
is to select compounds for further screening in 
programs such as ToxCast. ToxCast phase I 
is using a set of compounds (primarily pesti-
cide active ingredients) that are amenable to 
HTS and that have rich toxicologic data. The 
outcome of the phase I analyses will be a set of 
“signatures” that use in vitro screening data as 
inputs to predict in vivo toxicology phenotypes 
with high enough sensitivity and specificity to 
be useful for prioritization for more detailed 
testing. Phase II needs to include compounds 
that can be used to independently validate the 
phase I signatures. Therefore, the phase II set of 
chemicals should contain as many compounds 
as possible with high-quality in vivo toxicol-
ogy data, have physical–chemical properties 
that make them candidates for HTS, and be 
drawn from a more diverse collection than the 
phase I chemicals to help define the chemi-
cal domain of applicability of the signatures. 
We calculated the intersection of the set of 
2,767 chemicals that have data from one of 
the high-quality and/or systematic toxicol-
ogy data sources (NTP, IRIS, HPVIS, OPP/
ToxRefDB, OECD SIDS, IARC, ATSDR) 
with the set of 3,060 chemicals with reasonable 
physicochemical properties. This yields a list of 
1,308 candidate chemicals that have both high-
quality toxicity data and physicochemical prop-
erties very well suited for HTS. After removing 
the ToxCast phase I chemicals, we arrived at 
a list of 1,046 chemicals that are candidates 
for inclusion in ToxCast phase II for use in 
validating ToxCast phase I findings across a 
Table 5. Production volumes from the 2002 IUR.
Production volume (lb/year)  Count  Percent coverage
 < 10K  11  0.1
10K–500K  2,827  29.0
 > 500K–1M  485  4.9
 > 1M–10M  1,381  14.0
 > 10M–50M  512  5.0
 > 50M–100M  130  1.0
 > 100M–500M  246  2.0
 > 500M–1B  67  0.7
 > 1B  280  3.0
Total  5,939  60.0
Abbreviations: B, billion; K, thousand; M, million. Figure 1. Distribution of MW for representative chemical sets. The sum of fractions for each data set equals 1.
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variety of end points. Many of these chemicals 
are currently being analyzed in a series of HTS 
assays at the NIH Chemical Genomic Center 
(NCGC) as part of the Tox21 partnership 
between U.S. EPA, NCGC, and NTP. These 
Tox21 chemicals include an even broader 
range of physicochemical properties, with a 
MW range of 32 to 1,255 and a logP range 
of –13.2 to 13.2. An important analysis that 
is yet to be carried out is chemical structure 
characterization and clustering for the ToxCast 
phase I and II lists and the larger target list. 
This will be important to help understand our 
ability to extrapolate within and across chemical 
structural classes.
ACToR is not alone in its goal of aggregat-
ing large sets of chemical structure and assay 
data but is distinguished from other efforts 
by its focus on toxicology and environmen-
tal chemicals and its goal of facilitating com-
putational analysis. PubChem (NCBI 2008) 
is the largest effort currently available, with 
information on more than 10 million unique 
chemical compounds. ChemSpider (2008) is 
an even larger chemical aggregation project but 
does not house biological data or download-
able data sets. Another important compari-
son is with TOXNET, which is a collection of 
multiple data sources covering many aspects of 
chemical toxicity. TOXNET has a common 
search engine that allows the user to easily find 
data from multiple sources. However, it is a 
closed system that does not allow a user to pull 
together data sets that are useful for compu-
tational purposes. One unique aspect of the 
ACToR system is that it aggregates the data 
from PubChem (focused on chemical structure 
and HTS in vitro assay data) and TOXNET 
(NLM 2008) (focused on in vivo toxicology 
data) and combines it in a way that it can be 
used for computational analysis. eChemPortal 
(OECD 2008) is an OECD effort very similar 
to ACToR. It mainly aggregates information 
on HPV chemicals and pesticides. eChem 
Portal currently contains links to seven large 
database systems, some of which contain what 
in ACToR are multiple individual databases 
(e.g., INCHEM contains 11 individual data-
bases; International Programme on Chemical 
Safety 2008). Unlike eChemPortal, which pro-
vides links to Web pages for the component 
databases, ACToR extracts tabular data from 
a large number of sources and makes it search-
able by name, CASRN, or chemical structure. 
A system called Vitic is being developed by 
Lhasa Limited in collaboration between the 
European Chemicals Agency’s International 
Uniform Chemical Information Database 
(IUCLID 2008) project and a number of phar-
maceutical companies, with the goal of being 
an international toxicology information center 
(Judson et al. 2005). In addition, the European 
Substances Information System provides links 
to a number of databases, including U.S. EPA 
HPV, IUCLID, and European Inventory of 
Existing Commercial Chemical Substances. 
Finally, the Chemical Effects in Biological 
Systems project at the National Institute of 
Environmental Health Sciences is constructing 
a multidomain information repository to hold 
the detailed results and summaries of in vivo 
and in vitro toxicology experiments from NTP 
studies, with particular emphasis on toxico-
genomics and microarray experiments (Waters 
et al. 2008).
To adequately characterize the toxicology 
of all environmental chemicals of potential 
concern, we still face significant challenges. 
Screening and prioritization approaches such as 
ToxCast can make significant headway in ana-
lyzing small organic and organometallic com-
pounds, for which most HTS methods have 
been developed for use in the pharmaceutical 
industry. Because of solubility and volatility 
issues, however, many exceptionally high- and 
low-MW environmental compounds or highly 
lipophilic compounds may require new screen-
ing methods. Of special interest are nano-
materials, which will require new standards for 
description (i.e., size, shape, composition, etc.) 
and may require entirely new approaches to 
thinking about cellular and organism-level tox-
icity (Maynard et al. 2006; Shaw et al. 2008). 
One rarely has knowledge of metabolites that 
can arise from a parent compound in vivo and 
whether any of these metabolites are more or 
less toxic than the parent. However, a number 
of metabolic pathway databases and/or simula-
tors are currently available or under develop-
ment that could potentially be incorporated 
into ACToR in the future. Finally, a large 
number of known biological pathways (i.e., 
signaling, metabolism, etc.) have the potential 
to lead to toxicity when significantly perturbed. 
Many toxicity pathways have been implicated 
in whole-animal end points, such as liver can-
cer, and most chemicals can perturb multiple 
candidate toxicity pathways. Gaining a predic-
tive and mechanistic understanding of chemi-
cal toxicity will require the ability to predict 
which set of toxicity pathways are triggered by 
individual chemicals.
A significant amount of data on chemicals 
is not currently accessible for modeling, either 
because it is not publicly available or because 
it is not yet extracted from primary reports 
in a useful, tabular format. Several efforts are 
under way at the U.S. EPA and other institu-
tions to extract, standardize, compile, and ana-
lyze such high-quality data (U.S. EPA 2008b). 
We would welcome collaborations with other 
groups producing such tabular data sets on 
these important classes of chemicals.
Conclusions
In this article, we have described a process for 
determining a set of environmental chemi-
cals with the highest need for hazard and risk 
evaluation, which is based primarily on objec-
tive, simple measures of data availability. In 
addition, we have collected information from 
a large number of publicly available sources 
to determine the state of our current knowl-
edge of these chemicals. The list we developed 
includes HPV and MPV chemicals, pesticide 
and antimicrobial active and inert ingredi-
ents, and potential air and drinking water 
pollutants, in addition to chemicals already 
being evaluated by the U.S. EPA IRIS and 
ToxCast programs. Although the input lists 
are developed from the perspective of regula-
tory and research needs of the U.S. EPA, we 
believe that our overall conclusions will have 
wide applicability. This process resulted in 
a collection of 9,912 unique chemicals. We 
have at least limited hazard information on 
approximately two-thirds of these and detailed 
toxicology information on approximately 
Figure 2. Distribution of calculated logP for representative chemical sets. The sum of fractions for each 
data set equals 1.
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one-quarter. The combination of chemical 
structure and in vivo data on this large range 
of environmental chemicals in ACToR can 
facilitate structure–activity relationship and 
other types of trend analyses. These analyses 
will have direct relevance to U.S. EPA pro-
grams such as HPV Challenge (U.S. EPA 
2008m) and the Chemical Assessment and 
Management Program (U.S. EPA 2008b).
The principal reason for the lack of more 
complete toxicity information is the extremely 
high cost for full evaluation using standard 
guideline animal studies, which is millions of 
dollars per chemical. This has prompted the 
call for the use of more cost-effective HTS 
methods for quickly screening and prioritiz-
ing chemicals for more detailed testing. The 
analysis presented here is a first step in such 
a screening and prioritization process being 
carried out at the U.S. EPA as part of the 
ToxCast program. ToxCast is using hun-
dreds of in vitro HTS assays to assess poten-
tial mechanisms through which chemicals 
could cause toxicity. This hazard prediction is 
just one of several axes along which potential 
risk needs to be evaluated. Chemicals need 
to be evaluated for exposure potential, and 
for adsorption, distribution, metabolism, 
and excretion (ADME) and pharmacokinet-
ics properties. Of special concern would be 
compounds that are persistent or bioaccu-
mulative. Researchers at Health Canada have 
demonstrated a process to evaluate exposure 
for many of these chemicals (Health Canada 
2006). Chemical structure analysis can be 
used as part of the prioritization process, 
for instance, in predicting bioaccumulation 
potential (Meylan et al. 1999; Weisbrod 
et al. 2007) and fractional absorption (Ekins 
et al. 2007a, 2007b). Nonanimal experimen-
tal methods are available to approximate gut 
absorption (Sun et al. 2008) and total hepatic 
clearance (Naritomi et al. 2003). Reverse-
pharmacokinetic methods (Brightman et al. 
2006) can be used to predict oral doses that 
would be required to trigger molecular pro-
cesses, for instance, based on half maximal 
inhibitory concentrations (IC50) for recep-
tor binding from in vitro assays. These and 
other related approaches are being considered 
as part of the overall ToxCast screening and 
prioritization process. Of special relevance to 
the ToxCast program, we have identified a set 
of 1,046 candidate chemicals that have reli-
able in vivo toxicology data and have physico-
chemical properties that make them suitable 
for in vitro HTS analysis. These are candidates 
for phase II of the ToxCast program, which 
will be used to validate in vitro-to-in vivo tox-
icity predictions, which are one outcome of 
phase I of this program.
Another important input to this process is 
high-quality, tabular in vivo toxicity data. This 
is required to anchor our in vitro-to-in vivo 
prediction models, in both the model build-
ing and model validation phases. Initially, 
we are making use of the results of guideline 
toxicology studies for pesticide active ingredi-
ents, which are being collected into the U.S. 
EPA ToxRefDB (Martin et al. 2008). We are 
expanding this data collation effort in coordi-
nation with the ACToR project. As already 
described, ACToR is a database consisting 
of information on environmental chemicals 
from a wide number of sources. However, 
currently much of the high-quality toxicology 
data indexed in ACToR still resides in text 
reports and remains to be manually extracted 
into tabular form.
An important aspect of this program is 
openness and transparency. The ToxCast 
program is making all of its data publicly 
available. It has a large community of col-
laborators, from government labs, compa-
nies, and universities. Finally, important open 
venues for learning about this program and 
the Chemical Prioritization and Exposure 
Communities of Practice are providing 
input (U.S. EPA 2008i). These are bringing 
together representatives from U.S. EPA, state, 
and other national environmental regulatory 
organizations, academic labs, stakeholder 
companies, and public interest groups, all of 
whom are providing important input as we 
collectively work to address this important 
problem. All of these efforts are consistent 
with achieving the goals and vision of the 
recent NRC report Toxicity Testing in the 21st 
Century (NRC 2007).
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